Road to Alzheimer's disease: the pathomechanism underlying
- PMID: 22205086
- DOI: 10.1159/000332218
Road to Alzheimer's disease: the pathomechanism underlying
Abstract
Alzheimer's disease (AD), the most common cause of dementia, results from the interplay of various deregulated mechanisms triggering a complex pathophysiology. The neurons suffer from and slowly succumb to multiple irreversible damages, resulting in cell death and thus memory deficits that characterize AD. In spite of our vast knowledge, it is still unclear as to when the disease process starts and how long the perturbations continue before the disease manifests. Recent studies provide sufficient evidence to prove amyloid β (Aβ) as the primary cause initiating secondary events, but Aβ is also known to be produced under normal conditions and to possess physiological roles, hence, the questions that remain are: What are the factors that lead to abnormal Aβ production? When does Aβ turn into a pathological molecule? What is the chain of events that follows Aβ? The answers are still under debate, and further insight may help us in creating better diagnostic and therapeutic options in AD. The present article attempts to review the current literature regarding AD pathophysiology and proposes a pathophysiologic cascade in AD.
Copyright © 2011 S. Karger AG, Basel.
Similar articles
-
The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.Acc Chem Res. 2011 Nov 15;44(11):1146-55. doi: 10.1021/ar200014u. Epub 2011 Jun 29. Acc Chem Res. 2011. PMID: 21714485
-
Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools.J Phys Condens Matter. 2012 Jun 20;24(24):244102. doi: 10.1088/0953-8984/24/24/244102. Epub 2012 May 18. J Phys Condens Matter. 2012. PMID: 22595372 Review.
-
[Oxidative stress and Alzheimer's disease].Sheng Li Xue Bao. 2012 Feb 25;64(1):87-95. Sheng Li Xue Bao. 2012. PMID: 22348966 Review. Chinese.
-
β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.Free Radic Biol Med. 2011 Jan 1;50(1):122-9. doi: 10.1016/j.freeradbiomed.2010.10.707. Epub 2010 Oct 26. Free Radic Biol Med. 2011. PMID: 21034809
-
Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.Mol Biosyst. 2011 Jun;7(6):1822-7. doi: 10.1039/c0mb00302f. Epub 2011 Mar 24. Mol Biosyst. 2011. PMID: 21431241 Review.
Cited by
-
A Series of Novel 1-H-isoindole-1,3(2H)-dione Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: In Silico, Synthesis and In Vitro Studies.Molecules. 2024 Jul 26;29(15):3528. doi: 10.3390/molecules29153528. Molecules. 2024. PMID: 39124935 Free PMC article.
-
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.BioDrugs. 2017 Aug;31(4):317-334. doi: 10.1007/s40259-017-0234-5. BioDrugs. 2017. PMID: 28669112 Free PMC article. Review.
-
Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.Mol Neurobiol. 2022 Jun;59(6):3402-3413. doi: 10.1007/s12035-022-02793-8. Epub 2022 Mar 21. Mol Neurobiol. 2022. PMID: 35312967 Free PMC article.
-
Spontaneous and induced nontransgenic animal models of AD: modeling AD using combinatorial approach.Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):318-26. doi: 10.1177/1533317513488914. Epub 2013 May 17. Am J Alzheimers Dis Other Demen. 2013. PMID: 23687185 Free PMC article. Review.
-
Okadaic Acid and Hypoxia Induced Dementia Model of Alzheimer's Type in Rats.Neurotox Res. 2019 Apr;35(3):621-634. doi: 10.1007/s12640-019-0005-9. Epub 2019 Feb 7. Neurotox Res. 2019. PMID: 30729451
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical